CDH1 and cancer: As E-cadherin (CDH1) downregulation in cancer cells often occurs as a result of promoter methylation, loss of promoter methylation at the secondary site causes the metastatic cancer cells to re-express E-cadherin through MET [108,109,110,111,112,113,114,115,116,117,118].